HENDERSON MICHAEL THOMAS sold APGE

June 22, 2026 · Form 4 insider transaction

HENDERSON MICHAEL THOMAS sold 80,000 shares of Apogee Therapeutics Inc at $132.54 per share, a transaction worth $10.60M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
80,000
Price
$132.54
Total value
$10.60M
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 22, 2026
Filing dateJune 24, 2026
Shares owned after1,015,987
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.; The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.50 to $132.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

View the original Form 4 on SEC EDGAR